Concord Medical Services Holdings is a medical care facilities business based in the US. Concord Medical Services shares (CCM) are listed on the NYSE and all prices are listed in US Dollars. Concord Medical Services employs 972 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $1.95 |
|---|---|
| 52-week range | $1.15 - $3.40 |
| 50-day moving average | $1.65 |
| 200-day moving average | $2.08 |
| Wall St. target price | $1.20 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-2.80 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.95 from 2022-07-01
| 1 week (2022-06-28) | -2.99% |
|---|---|
| 1 month (2022-06-06) | 12.72% |
| 3 months (2022-04-06) | 2.63% |
| 6 months (2022-01-06) | 3.72% |
| 1 year (2021-07-06) | -31.58% |
|---|---|
| 2 years (2020-07-06) | 20.00% |
| 3 years (2019-07-05) | 2.4 |
| 5 years (2017-07-05) | 3.89 |
| Revenue TTM | $485.6 million |
|---|---|
| Gross profit TTM | $-56,897,000 |
| Return on assets TTM | -4.95% |
| Return on equity TTM | -20.32% |
| Profit margin | -55.89% |
| Book value | $2.81 |
| Market capitalisation | $84.7 million |
TTM: trailing 12 months
We're not expecting Concord Medical Services to pay a dividend over the next 12 months.
Concord Medical Services's shares were split on a 11384:1000 basis on 15 January 2014. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 11384 shares. This wouldn't directly have changed the overall worth of your Concord Medical Services shares – just the quantity. However, indirectly, the new 91.2% lower share price could have impacted the market appetite for Concord Medical Services shares which in turn could have impacted Concord Medical Services's share price.
Over the last 12 months, Concord Medical Services's shares have ranged in value from as little as $1.15 up to $3.3972. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Concord Medical Services's is -0.0331. This would suggest that Concord Medical Services's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Concord Medical Services has bucked the trend.
Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.